Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). / Fang, Evandro Fei; Froetscher, Lynn; Scheibye-Knudsen, Morten; Bohr, Vilhelm A; Wong, Jack Ho; Ng, Tzi Bun.

In: Current Protein and Peptide Science, Vol. 20, No. 3, 2019, p. 296-301.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Fang, EF, Froetscher, L, Scheibye-Knudsen, M, Bohr, VA, Wong, JH & Ng, TB 2019, 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein and Peptide Science, vol. 20, no. 3, pp. 296-301. https://doi.org/10.2174/1389203719666180622095800

APA

Fang, E. F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V. A., Wong, J. H., & Ng, T. B. (2019). Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). Current Protein and Peptide Science, 20(3), 296-301. https://doi.org/10.2174/1389203719666180622095800

Vancouver

Fang EF, Froetscher L, Scheibye-Knudsen M, Bohr VA, Wong JH, Ng TB. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). Current Protein and Peptide Science. 2019;20(3):296-301. https://doi.org/10.2174/1389203719666180622095800

Author

Fang, Evandro Fei ; Froetscher, Lynn ; Scheibye-Knudsen, Morten ; Bohr, Vilhelm A ; Wong, Jack Ho ; Ng, Tzi Bun. / Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). In: Current Protein and Peptide Science. 2019 ; Vol. 20, No. 3. pp. 296-301.

Bibtex

@article{06301c7977fa4e08a2859b21db4b8a6d,

title = "Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)",

abstract = "Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.",

author = "Fang, {Evandro Fei} and Lynn Froetscher and Morten Scheibye-Knudsen and Bohr, {Vilhelm A} and Wong, {Jack Ho} and Ng, {Tzi Bun}",

note = "Copyright{\textcopyright} Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.",

year = "2019",

doi = "10.2174/1389203719666180622095800",

language = "English",

volume = "20",

pages = "296--301",

journal = "Current Protein and Peptide Science",

issn = "1389-2037",

publisher = "Bentham Science Publishers",

number = "3",

}

RIS

TY - JOUR

T1 - Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)

AU - Fang, Evandro Fei

AU - Froetscher, Lynn

AU - Scheibye-Knudsen, Morten

AU - Bohr, Vilhelm A

AU - Wong, Jack Ho

AU - Ng, Tzi Bun

PY - 2019

Y1 - 2019

N2 - Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.

AB - Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.

U2 - 10.2174/1389203719666180622095800

DO - 10.2174/1389203719666180622095800

M3 - Journal article

C2 - 29932035

VL - 20

SP - 296

EP - 301

JO - Current Protein and Peptide Science

JF - Current Protein and Peptide Science

SN - 1389-2037

IS - 3

ER -

ID: 213162792